Published on

Medicine – Pancytopenia

Pancytopenia is a haematological condition characterised by a reduction in all three major peripheral blood cell lines:

  • Red blood cells: Anaemia.
  • White blood cells: Leukopenia, often with neutropenia.
  • Platelets: Thrombocytopenia.

Pancytopenia is not a disease itself but a manifestation of an underlying disorder affecting blood cell production, survival or distribution.

Important Clinical Principle

The major causes of pancytopenia include aplastic anaemia, megaloblastic anaemia, bone marrow failure or infiltration, and hypersplenism.

1. Pathophysiology

Pancytopenia develops through three principal mechanisms:

  1. Reduced bone marrow production: Failure or ineffective production of blood cells.
  2. Bone marrow infiltration or replacement: Disruption of normal haematopoiesis by malignant cells or fibrosis.
  3. Peripheral sequestration or destruction: Increased removal of blood cells from the circulation, particularly in hypersplenism.

Pathophysiology Flowchart

Pancytopenia Reduced Marrow Production Aplastic anaemia B12 / folate deficiency Marrow Infiltration Leukaemia Myelofibrosis / cancer Sequestration / Destruction Hypersplenism Immune / infective Reduced Circulating Blood Cells Anaemia + Leukopenia + Thrombocytopenia

2. Causes of Pancytopenia

A. Aplastic Anaemia

Aplastic anaemia is a bone marrow failure syndrome characterised by markedly reduced haematopoietic stem cells and a hypocellular bone marrow.

Causes

  • Idiopathic or immune-mediated aplastic anaemia.
  • Cytotoxic chemotherapy.
  • Radiotherapy.
  • Certain medications, including chloramphenicol and some antithyroid drugs.
  • Viral infections, including hepatitis-associated aplastic anaemia.
  • Inherited marrow failure syndromes, such as Fanconi anaemia.

Characteristic Findings

  • Pancytopenia.
  • Low reticulocyte count.
  • Hypocellular bone marrow.
  • Usually no splenomegaly in uncomplicated aplastic anaemia.
Examination Pearl: Pancytopenia with a hypocellular bone marrow strongly suggests aplastic anaemia.

B. Megaloblastic Anaemia

Megaloblastic anaemia results from impaired DNA synthesis, most commonly due to vitamin B12 or folate deficiency.

Severe deficiency may produce pancytopenia because all three blood cell lines are affected.

Characteristic Findings

  • Macrocytosis.
  • Macro-ovalocytes.
  • Hypersegmented neutrophils.
  • Low reticulocyte count before treatment.
  • Hypercellular bone marrow with ineffective haematopoiesis.
Examination Pearl: Pancytopenia with macro-ovalocytes and hypersegmented neutrophils strongly suggests megaloblastic anaemia.

C. Bone Marrow Disorders and Infiltration

Diseases that replace or disrupt normal bone marrow can suppress the production of all three blood cell lines.

Cause Mechanism
Leukaemia Accumulation of malignant cells suppresses normal haematopoiesis.
Myelodysplastic neoplasms (MDS) Ineffective and dysplastic blood cell production.
Myelofibrosis Marrow fibrosis disrupts normal haematopoiesis.
Multiple myeloma Plasma cell infiltration may suppress marrow function.
Metastatic carcinoma Malignant infiltration replaces normal marrow.
Lymphoma Bone marrow infiltration may produce cytopenias.

Leukaemia

Acute leukaemias, including AML and ALL, commonly produce pancytopenia through marrow replacement.

The peripheral blood film may show circulating blasts, although blasts are not always present.

Myelodysplastic Neoplasms

MDS involves clonal abnormalities of haematopoietic stem cells, resulting in ineffective blood cell production.

It is more common in older adults and may progress to acute myeloid leukaemia.

Myelofibrosis

Myelofibrosis may cause pancytopenia, particularly in advanced disease.

Typical blood film findings include:

  • Tear-drop cells (dacrocytes).
  • Nucleated red blood cells.
  • Immature granulocytes.
  • Leucoerythroblastic blood picture.

Multiple Myeloma, Carcinoma and Lymphoma

These malignancies may infiltrate the marrow and impair normal blood cell production.

Metastatic marrow infiltration may also produce a leucoerythroblastic blood picture.

D. Hypersplenism

Hypersplenism refers to increased sequestration and destruction of circulating blood cells by an enlarged or overactive spleen.

Common Causes

  • Liver cirrhosis with portal hypertension.
  • Chronic liver disease.
  • Haematological malignancies.
  • Certain infections.
  • Infiltrative splenic disorders.

Characteristic Features

  • Splenomegaly, although spleen size varies.
  • Thrombocytopenia, often the earliest or most prominent cytopenia.
  • Anaemia and leukopenia in more pronounced cases.
  • Bone marrow production may be preserved or increased.
Important Distinction: Aplastic anaemia involves reduced marrow production, whereas hypersplenism predominantly involves increased splenic sequestration of circulating blood cells.

3. Other Important Causes

Additional causes of pancytopenia include:

  • Severe infections, including HIV, tuberculosis and some viral infections.
  • Sepsis.
  • Haemophagocytic lymphohistiocytosis (HLH).
  • Autoimmune disorders, particularly systemic lupus erythematosus.
  • Copper deficiency.
  • Drugs causing marrow suppression or immune-mediated cytopenias.
  • Paroxysmal nocturnal haemoglobinuria (PNH), particularly when associated with marrow failure.

4. Clinical Features

Clinical manifestations arise from the reduction in each blood cell line.

Deficient Cell Line Clinical Manifestations
Red blood cells Pallor, fatigue, dyspnoea, dizziness, palpitations.
Neutrophils Fever, recurrent infections, sepsis.
Platelets Petechiae, purpura, bruising, epistaxis, gum bleeding.

Additional Clinical Findings

  • Splenomegaly: Hypersplenism, myelofibrosis or haematological malignancy.
  • Lymphadenopathy: Leukaemia, lymphoma or infection.
  • Bone pain: Marrow infiltration or malignancy.
  • Neurological abnormalities: Vitamin B12 deficiency.
  • Weight loss and night sweats: Possible malignancy or chronic infection.

5. Investigations

A. Full Blood Count

The full blood count confirms reduction in all three major blood cell lines.

The severity and pattern of cytopenias help guide further assessment.

B. Peripheral Blood Film

Blood Film Finding Possible Diagnosis
Macro-ovalocytes and hypersegmented neutrophilsMegaloblastic anaemia
Circulating blastsAcute leukaemia
Tear-drop cellsMyelofibrosis or marrow infiltration
Leucoerythroblastic pictureMarrow infiltration or fibrosis
Dysplastic neutrophils or other cellsMyelodysplastic neoplasm
Relatively unremarkable RBC morphology with cytopeniasMay occur in aplastic anaemia

C. Reticulocyte Count

The reticulocyte count helps assess bone marrow red cell production.

  • Low reticulocyte count: Suggests impaired red cell production.
  • Raised reticulocyte count: May indicate haemolysis or blood loss, although interpretation depends on the severity of anaemia.

D. Additional Blood Investigations

  • Vitamin B12 and folate.
  • Liver and renal function tests.
  • LDH, bilirubin and haptoglobin.
  • Viral testing when indicated.
  • Autoimmune investigations when appropriate.
  • Copper studies in selected cases.

E. Bone Marrow Examination

Bone marrow aspiration and trephine biopsy may be required when the cause remains unclear or marrow disease is suspected.

Bone Marrow Finding Possible Diagnosis
Hypocellular marrowAplastic anaemia
Megaloblastic erythropoiesisVitamin B12 or folate deficiency
Increased blastsAcute leukaemia
DysplasiaMyelodysplastic neoplasm
FibrosisMyelofibrosis
Malignant cell infiltrationMyeloma, lymphoma or metastatic carcinoma

6. Diagnostic Approach

Confirmed Pancytopenia Assess clinical urgency Blood Film + Reticulocytes History, examination and medications Targeted Investigations B12 / folate / liver tests Infection, haemolysis and other tests Bone Marrow Examination When indicated by clinical findings Identify and Treat Cause Provide supportive care as needed

7. Management

Management depends on the underlying cause of pancytopenia.

Cause General Treatment Approach
Aplastic anaemiaImmunosuppressive therapy or stem cell transplantation in selected patients
Megaloblastic anaemiaVitamin B12 or folate replacement as appropriate
LeukaemiaDisease-specific chemotherapy, targeted therapy or transplantation
Myelodysplastic neoplasmSupportive care and risk-adapted treatment
MyelofibrosisDisease-specific therapy and supportive care
Marrow infiltrationTreatment of the underlying malignancy
HypersplenismManagement of the underlying cause

Supportive Care

  • Red blood cell transfusions when clinically indicated.
  • Platelet transfusions when indicated.
  • Prompt assessment and treatment of infection.
  • Review and withdrawal of causative drugs when appropriate.
  • Monitoring of blood counts and complications.

When vitamin B12 deficiency is possible, it should be assessed and treated appropriately; folate alone may correct anaemia while neurological injury from B12 deficiency continues.

8. High-Yield Examination Summary

Feature Key Point
DefinitionReduction in RBCs, WBCs and platelets
Aplastic anaemiaHypocellular marrow
Megaloblastic anaemiaMacro-ovalocytes and hypersegmented neutrophils
LeukaemiaMarrow infiltration by blasts
MyelodysplasiaIneffective, dysplastic haematopoiesis
MyelofibrosisTear-drop cells and marrow fibrosis
MyelomaPlasma cell infiltration
Carcinoma / lymphomaMalignant marrow infiltration
HypersplenismSplenic sequestration of blood cells
Key initial investigationsFBC, blood film and reticulocyte count
Bone marrow investigationAspiration and trephine biopsy when indicated

9. Key Examination Pearls

  • Pancytopenia is a finding, not a final diagnosis.
  • Aplastic anaemia causes pancytopenia with a hypocellular bone marrow.
  • Severe vitamin B12 or folate deficiency can cause pancytopenia.
  • Acute leukaemia may present with pancytopenia even without a high white cell count.
  • Tear-drop cells suggest myelofibrosis or marrow infiltration.
  • A leucoerythroblastic blood picture suggests disruption of normal marrow architecture.
  • Hypersplenism causes sequestration of blood cells, often with prominent thrombocytopenia.
  • The reticulocyte count helps assess marrow red cell production.
  • Bone marrow examination is important when a primary marrow disorder is suspected.
Most Important Examination Point

Pancytopenia with a hypocellular marrow suggests aplastic anaemia; pancytopenia with macro-ovalocytes and hypersegmented neutrophils suggests megaloblastic anaemia; and pancytopenia with tear-drop cells and a leucoerythroblastic blood picture suggests marrow fibrosis or infiltration.

Clinical Warning

Pancytopenia accompanied by fever, severe neutropenia, active bleeding or haemodynamic instability requires urgent medical assessment.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments